세계의 컴퓨터 지원 진단 시장 규모 : 영상 모달리티별, 용도별, 지역 범위별, 예측

Computer Aided Diagnosis Market Size And Forecast

Computer Aided Diagnosis Market size was valued at USD 792.33 Million in 2024 and is projected to reach USD 1211.21 Million by 2032, growing at a CAGR of 6.01% from 2026 to 2032.

Global Computer Aided Diagnosis Market Drivers

The market drivers for the Computer Aided Diagnosis Market can be influenced by various factors. These may include:

Technological Advancements: The accuracy and efficiency of CAD systems are being improved by ongoing developments in artificial intelligence (AI) algorithms and imaging modalities (such as MRI, CT scans, and X-rays), which is propelling market expansion.

Growing Prevalence of Chronic Diseases: Early and accurate diagnosis is necessary due to the rising prevalence of chronic diseases such as cancer, cardiovascular disease, and neurological disorders. CAD systems can offer this, which is boosting demand in the market.

Growing Aging Population: As the world's population ages, age-related diseases-which frequently call for diagnostic imaging-are more common. CAD systems promote market expansion by assisting in the early diagnosis and detection of such problems.

for Non-Invasive Diagnostic Procedures: By providing non-invasive diagnostic options, computer-aided diagnostic systems (CAD) lessen patient discomfort and the possibility of invasive procedure-related problems. This is what propels the use of CAD technology, especially in fields like breast cancer detection.

Government financing and Initiatives: The use of CAD systems can be increased by providing financing and encouraging the development of healthcare infrastructure, particularly in emerging economies.

Growing Healthcare Expenditure: The global increase in healthcare spending, particularly in industrialized nations, allows medical facilities to purchase sophisticated diagnostic tools such as computer-aided diagnosis (CAD) systems.

Requirement for Efficient Delivery of Healthcare: CAD systems reduce diagnostic mistakes and streamline the diagnostic process, enhancing workflow efficiency for healthcare practitioners. The adoption of CAD technology is driven by the demand for efficiency in the delivery of healthcare.

Education and Awareness Campaigns: Raising patient and healthcare provider acceptance of CAD systems is facilitated by education campaigns about the advantages of early diagnosis and technological improvements in medical imaging.

Integration with Electronic Health Records (EHR) Systems: The smooth exchange of information and decision-making that results from the integration of CAD and EHR systems improves data accessibility and interoperability and propels market expansion.

Global Computer Aided Diagnosis Market Restraints

Several factors can act as restraints or challenges for the Computer Aided Diagnosis Market. These may include:

High expenditures: The initial investment for CAD systems is frequently substantial and includes expenditures for training, software, and hardware. Healthcare facilities may find this high implementation cost to be a significant obstacle, especially in poor nations or smaller establishments.

Integration Challenges: It can be difficult and expensive to integrate CAD systems with the current healthcare infrastructure, which includes picture archiving and communication systems (PACS) and electronic health records (EHR). Adoption rates may be slowed by compatibility problems and interoperability difficulties.

Regulatory Obstacles: There are strict regulations governing CAD systems used in medical diagnostics, especially with regard to data privacy, safety, and efficacy. The process of obtaining regulatory approval can be costly and time-consuming, which delays the introduction of new ideas and products onto the market.

Limited Clinical Evidence: Although CAD technology has advanced, there may not be enough solid clinical evidence to support its value in enhancing patient outcomes or diagnostic accuracy. Healthcare providers may be reluctant to widely implement CAD systems as a result of this uncertainty.

Dependency on Expertise: CAD systems frequently use algorithms that have been trained using expert-curated datasets. The accuracy and dependability of CAD algorithms are, however, affected by the quality and representativeness of these datasets, which can differ, especially when it comes to rare diseases or varied patient populations.

Workflow Disruption: Integrating CAD systems into clinical workflows may cause established procedures to change, and medical professionals may need to receive training in order to use the technology properly. Adoption rates may be slowed by healthcare workers' resistance to change and worries about interruptions to workflow.

Data Security Issues: Because CAD systems handle vast amounts of private patient data, there are issues with data security, privacy, and possible breaches. For CAD vendors and healthcare institutions, maintaining patient information security and compliance with data protection standards can be difficult yet necessary.

Global Computer Aided Diagnosis Market: Segmentation Analysis

The Global Computer Aided Diagnosis Market is Segmented on the basis of Imaging Modalities, Application, And Geography.

Computer Aided Diagnosis Market, By Imaging Modalities

• Mammography
• Nuclear Imaging
• Ultrasound Imaging
• Magnetic Resonance Imaging
• Others

Based on Imaging Modalities, the market is segmented into Mammography, Nuclear Imaging, Ultrasound Imaging, Magnetic Resonance Imaging, and Others. The segment is expected to hold the largest market share. These factors can be attributed to the growing incidence of cancer all over the world. According to the World Cancer Research Fund International 2012, North America and Oceania have the highest breast cancer rate.

Computer Aided Diagnosis Market, By Application

• Breast Cancer
• Lung Cancer
• Prostate Cancer
• Alzheimer's Disease
• Diabetic Retinopathy
• Others

Based on Application, the market is segmented into Breast Cancer, Lung Cancer, Prostate Cancer, Alzheimer's disease, Diabetic Retinopathy, and Others. The Breast Cancer segment is anticipated to have the highest CAGR in the forecasted period. The factors can be attributed to the rising awareness of regular breast cancer check-ups and the increasing prevalence of cancer.

Computer Aided Diagnosis Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

Based on Regional Analysis, the Global Computer Aided Diagnosis Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. The largest share of the market will be dominated by North America owing to shifting trends from image analysis & pattern recognition algorithms to workflow management functions for diseases & conditions and ongoing research & development in this segment. The Asia Pacific is expected to grow at the highest CAGR due to increasing government initiatives, an upsurge in the demand for medical tourism, and the growing cost-effective technologies in this region.

Key Players

• The major players in the Computer Aided Diagnosis Market are:
• Hologic
• AdvancedMD, Inc.
• Median Technologies
• Philips N.V.
• Canon Medical Systems
• Hitachi High Technologies Corporation
• Vucomp
• Siemens Healthcare
• EDDA Technology Inc.
• McKesson Corporation
• iCAD Inc

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL COMPUTER AIDED DIAGNOSIS MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY IMAGING MODALITIES

• 5.1 Overview
• 5.2 Mammography
• 5.3 Nuclear Imaging
• 5.4 Ultrasound Imaging
• 5.5 Magnetic Resonance Imaging
• 5.6 Others

6 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY APPLICATION

• 6.1 Overview
• 6.2 Breast Cancer
• 6.3 Lung Cancer
• 6.4 Prostate Cancer
• 6.5 Alzheimer's Disease
• 6.6 Diabetic Retinopathy
• 6.7 Others

7 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL COMPUTER AIDED DIAGNOSIS MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market Ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Hitachi High Technologies Corporation
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 Vucomp
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Siemens Healthcare
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 EDDA Technology, Inc.
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 McKesson Corporation
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 iCAD, Inc.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments

10 KEY DEVELOPMENTS

• 10.1 Product Launches/Developments
• 10.2 Mergers and Acquisitions
• 10.3 Business Expansions
• 10.4 Partnerships and Collaborations

11 Appendix

• 11.1 Related Research